Focus on the gut-liver axis
NorUDCA (24-nor-ursodeoxycholic acid) is a chemically modified bile acid that has already shown promising results in the treatment of liver diseases such as primary sclerosing...
Tag: liver
Risk assessment after severe complication of liver cirrhosis improved
Approximately half of patients with advanced liver disease have varicose veins in the oesophagus and stomach, and a more than a fifth of them experience...
Government u-turn on pledge to offer liver scans
The government has reneged on its pledge to offer liver scans in the newly announced Community Diagnostic Centres in England, warns the UK's leading liver...
Risk satisfaction to predict abnormal blood results
New study reveals way to predict side-effect risk from common immune suppressant medication: A major new study has found a method to identify people who...
Tick tock – the liver controls the circadian clock
Tick tock – the liver controls the circadian clock: University of Queensland-led research has revealed liver cells influence the body’s internal circadian clock, which was...
Some obesity-related genes protect people from type 2 diabetes
Some obesity-related genes protect people from type 2 diabetes, while others increase risk: New research presented today at the Diabetes UK Professional Conference 2023 and...
Struggling with hangxiety?
Struggling with hangxiety? Dr Luke Powles, Clinical Director at Bupa Health Clinics examines the physical effect of alcohol consumption in the immediate, short and long-term,...
Liver disease: New non-invasive method of risk assessment
In a recent study, an interdisciplinary research team from MedUni Vienna showed that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method...
Diseased male livers undergo sex-change
Diseased male livers undergo sex-change: The livers of men diagnosed with hepatic diseases change sex as part of a potential self-protective mechanism, according to University...
Start-up gets backing for liver disease treatment
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP...
